Dutz A - Search Results

1

Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.

Dutz A, Lühr A, Troost EGC, Agolli L, Bütof R, Valentini C, Baumann M, Vermeren X, Geismar D, Timmermann B, Krause M, Löck S. Dutz A, et al. Radiother Oncol. 2021 Jul;160:69-77. doi: 10.1016/j.radonc.2021.04.008. Epub 2021 Apr 17. Radiother Oncol. 2021. PMID: 33872640

2

[Proton therapy not superior to IMRT in locally advanced NSCLC].

Dutz A, Troost EGC, Löck S. Dutz A, et al. Strahlenther Onkol. 2018 Aug;194(8):790-793. doi: 10.1007/s00066-018-1321-3. Strahlenther Onkol. 2018. PMID: 29858611 German. No abstract available.

3

Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours.

Dutz A, Lühr A, Agolli L, Troost EGC, Krause M, Baumann M, Vermeren X, Geismar D, Schapira EF, Bussière M, Daly JE, Bussière MR, Timmermann B, Shih HA, Löck S. Dutz A, et al. Radiother Oncol. 2019 Jan;130:164-171. doi: 10.1016/j.radonc.2018.06.036. Epub 2018 Jul 20. Radiother Oncol. 2019. PMID: 30033385

4

Competing risks in survival data analysis.

Dutz A, Löck S. Dutz A, et al. Radiother Oncol. 2019 Jan;130:185-189. doi: 10.1016/j.radonc.2018.09.007. Epub 2018 Oct 9. Radiother Oncol. 2019. PMID: 30314718

5

Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.

Dutz A, Agolli L, Baumann M, Troost EGC, Krause M, Hölscher T, Löck S. Dutz A, et al. Acta Oncol. 2019 Jun;58(6):916-925. doi: 10.1080/0284186X.2019.1581373. Epub 2019 Mar 18. Acta Oncol. 2019. PMID: 30882264

6

Neurocognitive function and quality of life after proton beam therapy for brain tumour patients.

Dutz A, Agolli L, Bütof R, Valentini C, Baumann M, Lühr A, Löck S, Krause M. Dutz A, et al. Radiother Oncol. 2020 Feb;143:108-116. doi: 10.1016/j.radonc.2019.12.024. Epub 2020 Feb 8. Radiother Oncol. 2020. PMID: 32044170

7

Modelling of late side-effects following cranial proton beam therapy.

Dutz A, Lühr A, Agolli L, Bütof R, Valentini C, Troost EGC, Baumann M, Vermeren X, Geismar D, Lamba N, Lebow ES, Bussière M, Daly JE, Bussière MR, Krause M, Timmermann B, Shih HA, Löck S. Dutz A, et al. Radiother Oncol. 2021 Apr;157:15-23. doi: 10.1016/j.radonc.2021.01.004. Epub 2021 Jan 19. Radiother Oncol. 2021. PMID: 33482232

8

Predicting late magnetic resonance image changes in glioma patients after proton therapy.

Eulitz J, Troost EGC, Raschke F, Schulz E, Lutz B, Dutz A, Löck S, Wohlfahrt P, Enghardt W, Karpowitz C, Krause M, Lühr A. Eulitz J, et al. Among authors: dutz a. Acta Oncol. 2019 Oct;58(10):1536-1539. doi: 10.1080/0284186X.2019.1631477. Epub 2019 Jul 15. Acta Oncol. 2019. PMID: 31303083 No abstract available.

9

A Monte Carlo based radiation response modelling framework to assess variability of clinical RBE in proton therapy.

Eulitz J, Lutz B, Wohlfahrt P, Dutz A, Enghardt W, Karpowitz C, Krause M, Troost EGC, Lühr A. Eulitz J, et al. Among authors: dutz a. Phys Med Biol. 2019 Nov 21;64(22):225020. doi: 10.1088/1361-6560/ab3841. Phys Med Biol. 2019. PMID: 31374558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters